Niessner et al. measured serum Fas and TRAIL in 360 patients with advanced chronic heart failure (NYHA III or IV) who had been admitted to hospital due to heart failure decompensation, and followed them for 16 months [6]. The gene discussed is FAS; the disease is congestive heart failure.